University Of Nairobi
Clinical trials sponsored by University Of Nairobi, explained in plain language.
-
Trial tests best path forward for HIV patients with drug resistance
Disease control Recruiting nowThis study aims to find the best treatment strategy for people with HIV whose current dolutegravir (DTG) medication is no longer fully effective due to drug resistance. Researchers will randomly assign 392 participants, including some children, to either continue their DTG-based …
Phase: PHASE3 • Sponsor: University of Nairobi • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major study tests if counseling can avoid costly HIV drug switches
Disease control Recruiting nowThis study aims to find the best way to manage HIV when the preferred first-line drug, dolutegravir, isn't fully suppressing the virus. It will follow 6,600 people in four African countries who have high virus levels despite being on treatment. Researchers will see if intensive c…
Sponsor: University of Nairobi • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC